Symbol | Exchange | Currency |
|---|
Celldex (NASDAQ:CLDX) Therapeutics, Inc. (CLDX) today announced preclinical data from CDX-622, the Company’s bispecific antibody with dual targeting of the alarmin TSLP and stem...
Investing.com - Celldex Therapeutics (NASDAQ: CLDX) reported first quarter EPS of $-0.62, worse than the analyst estimate of $-0.62. Revenue for the quarter came in at $967K versus...
We’re well into the second half of 2021, and with any luck at all we’ll soon see last year’s major headwinds fully relegated to the rear-view mirror. Even so,...
Amgen Inc Amgen (NASDAQ:AMGN), which popped a couple weeks ago and pulled back to test the 50-day, forming a V-bottom and right-hand extension, exploded on Wednesday, jumping...
1. Akebia Therapeutics Akebia Therapeautics (NASDAQ:AKBA) actually broke out on Tuesday from a 2-month consolidation, popping 88 cents, or 7%, closing at the session high of the...
Celldex Therapeutics, Inc. is a biopharmaceutical company. It is focused on developing therapeutic monoclonal and bispecific antibodies that address diseases for which available treatments are inadequate. Its drug candidates include antibody-based therapeutics, which has the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis and Eosinophilic Esophagitis. Its bispecific platform includes CDX-585 and CDX-527. CDX-585 combines its active PD-1 blockade and anti-ILT4 blockade to prevent immunosuppressive signals in T cells and myeloid cells, respectively. Its other programs include CDX-1140, a fully human agonist monoclonal antibody targeted to CD40.
| Average | 66.33 (+106.44% Upside) |
| High | 73.00 |
| Low | 54.00 |
| Price | 32.13 |
| No. of Analysts | 6 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Buy | Buy | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy | Strong Sell | Sell |
| Summary | Strong Sell | Neutral | Strong Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 397.70 | 400.50 | 383.40 | +19.36 | +5.12% | 62.31M | NASDAQ | |||
| 207.52 | 209.80 | 199.37 | +3.59 | +1.76% | 147.24M | NASDAQ | |||
| 1.40 | 1.40 | 1.33 | +0.12 | +9.11% | 31.10K | OTC Markets | |||
| 61.50 | 62.40 | 59.04 | +1.11 | +1.84% | 8.66M | NYSE | |||
| 171.25 | 172.00 | 170.25 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 72.52 | 73.03 | 71.70 | +0.31 | +0.43% | 392.04K | NYSE | |||
| 34.72 | 37.25 | 30.26 | -5.29 | -13.22% | 82.91M | NYSE | |||
| 62.23 | 62.99 | 62.03 | -0.21 | -0.34% | 338.76K | NYSE | |||
| 17.89 | 17.89 | 17.62 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 3.87 | 3.92 | 3.77 | +0.02 | +0.41% | 26.97K | NASDAQ | |||
| 34.87 | 34.89 | 34.87 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 11.75 | 11.92 | 11.29 | +0.360 | +3.16% | 533.50K | NASDAQ | |||
| 10.99 | 11.00 | 10.99 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 24.82 | 24.85 | 24.75 | +0.05 | +0.20% | 293.73K | NYSE | |||
| 0.058 | 0.058 | 0.015 | 0.00 | 0.00% | 0.00 | OTC Markets |